From HVTN to CoVPN: the importance of vaccine trial networks

Lawrence Corey is a Professor at Fred Hutch and Principal Investigator of the HIV Vaccine Trials Network (HVTN), which conducts studies of HIV vaccines at over 80 clinical trial sites in 16 countries. Early in the COVID-19 pandemic, HVTN took a central role in the COVID-19 Prevention Network (CoVPN), which was responsible for conducting clinical trials of US government-sponsored COVID-19 vaccines and monoclonal antibodies. In this interview, Charlotte Barker, Editor, Vaccine Insights, speaks with Lawrence Corey about coordinating clinical trials during a pandemic and the lessons we can apply to future clinical research.

Please enter your email to access content Read now